Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

Pulmonary hypertension (PH) is characterized by a progressive elevation of mean arterial pressure followed by right ventricular failure and death. Previous studies have indicated that numerous inhibitors of receptor tyrosine kinase signaling could be either beneficial or detrimental for the treatmen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Veeroju, Swathi, Kojonazarov, Baktybek, Weiss, Astrid, Ghofrani, Hossein Ardeschir, Weissmann, Norbert, Grimminger, Friedrich, Seeger, Werner, Novoyatleva, Tatyana, Schermuly, Ralph Theo
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867319/
https://ncbi.nlm.nih.gov/pubmed/33540939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22031502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars